Sunny Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	47.77	138.02	270.56	222.63	229
Short-Term Investments	7.1	-	-	48.51	12.5
Cash & Short-Term Investments	54.87	138.02	270.56	271.14	241.5
Cash Growth	-60.25%	-48.98%	-0.21%	12.27%	-0.09%
Accounts Receivable	64.56	49.34	56.35	28.77	63.63
Other Receivables	0.67	2.26	0.8	1.78	7.17
Receivables	65.23	51.6	57.15	30.55	70.8
Inventory	80.14	123.49	97.04	71.94	97.6
Prepaid Expenses	47.21	48.64	28.65	21.75	18.4
Other Current Assets	-	3.1	7.1	18.6	43.48
Total Current Assets	247.44	364.86	460.49	413.98	471.78
Property, Plant & Equipment	1,003	1,092	1,156	1,102	946.12
Long-Term Investments	91.55	-	-	-	-
Goodwill	-	25.24	25.24	25.24	25.24
Other Intangible Assets	54.05	35.96	42.77	55.2	51.42
Other Long-Term Assets	6.54	69.2	27.91	32.76	100.16
Total Assets	1,403	1,587	1,712	1,630	1,595
Accounts Payable	8.28	16.88	26.13	12.34	23.17
Accrued Expenses	-	44.8	30.43	23.81	21.9
Short-Term Debt	143	20	-	190	50
Current Portion of Long-Term Debt	-	20.75	11.19	9.44	20.09
Current Portion of Leases	4.14	4.17	3.94	3.16	2.79
Current Unearned Revenue	30.64	32.5	19.19	12.48	10.87
Other Current Liabilities	86.01	25.85	20.95	29.03	36.89
Total Current Liabilities	272.06	164.94	111.83	280.25	165.7
Long-Term Debt	276.31	297.06	333.81	327.24	264.44
Long-Term Leases	40.17	44.31	42.49	32.86	28.98
Long-Term Unearned Revenue	52.03	27.13	17.07	12.74	1.46
Other Long-Term Liabilities	7.24	7.24	7.24	7.24	7.68
Total Liabilities	647.82	540.68	512.44	660.32	468.26
Common Stock	1,488	1,488	1,485	1,385	1,385
Additional Paid-In Capital	31.59	21.69	209.53	16.9	169.06
Retained Earnings	-765.01	-462.96	-496.17	-432.85	-427.84
Comprehensive Income & Other	-	0.41	1.32	-	-
Shareholders' Equity	754.95	1,047	1,200	969.3	1,126
Total Liabilities & Equity	1,403	1,587	1,712	1,630	1,595
Total Debt	463.62	386.29	391.43	562.69	366.3
Net Cash (Debt)	-408.76	-248.27	-120.87	-291.55	-124.8
Net Cash Per Share	-2.75	-1.67	-0.85	-2.10	-0.93
Filing Date Shares Outstanding	148.76	148.76	148.53	138.53	138.53
Total Common Shares Outstanding	148.76	148.76	148.53	138.53	138.53
Working Capital	-24.62	199.92	348.66	133.74	306.08
Book Value Per Share	5.07	7.04	8.08	7.00	8.13
Tangible Book Value	700.9	985.49	1,132	888.86	1,050
Tangible Book Value Per Share	4.71	6.62	7.62	6.42	7.58
Buildings	-	856.04	847.93	777.39	702.81
Machinery	-	856.02	822.27	587.06	512.13
Construction In Progress	-	2.69	4.44	162.91	64.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.